Buy Vital Therapies Stock | VTL Stock Price & Latest News | Public
VTL

Vital Therapies

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About VTL

    Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-83...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$363,6M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$23.39
    1 Year Low$4.19
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app